Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial

被引:7
|
作者
Blom, Kerstin [1 ,2 ]
Forsell, Erik [1 ,2 ]
Hellberg, Monica [2 ]
Svanborg, Cecilia [1 ,2 ]
Jernelov, Susanna [1 ,2 ,3 ]
Kaldo, Viktor [1 ,2 ,4 ]
机构
[1] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden
[2] Stockholm Hlth Care Serv, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden
[4] Linnaeus Univ, Fac Hlth & Life Sci, Dept Psychol, Vaxjo, Sweden
关键词
Insomnia; Depression; Comorbidity; Psychological treatment; Randomized controlled trial; COGNITIVE-BEHAVIORAL THERAPY; SLEEP RESTRICTION THERAPY; SELF-HELP; DSM-IV; MAJOR DEPRESSION; SOCIAL ANXIETY; FOLLOW-UP; CBT-I; METAANALYSIS; PHARMACOTHERAPY;
D O I
10.1159/000536063
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention. Methods: A 12-week double-blind randomized controlled trial with a 6-month follow-up in a psychiatric setting using therapist-guided internet-delivered treatments was conducted. Patients (N = 126) were diagnosed with insomnia disorder and major depression by physicians. Primary outcome measures were as follows: self-rating scales Insomnia Severity Index (ISI) and Montgomery-angstrom sberg Depression Rating Scale (MADRS-S). Results: The combined treatment showed specific effects on insomnia severity over the control treatment (p = 0.007) but was not more effective in reducing depression severity. Within-group effects (Cohen's d) at post and at 6 months were as follows: ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control); MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control). Conclusions: CBT-I shows large specific effects on insomnia severity and is superior to control in this regard. Both treatments had similar effects on depression severity, i.e., combining CBT-I with CBT for depression did not enhance outcomes on depression compared to control. We suggest CBT-I should always be offered to patients with insomnia and depression comorbidity, possibly as the first-hand choice. Combining it with a psychological treatment for depression could be too burdening and may not be beneficial.
引用
收藏
页码:100 / 113
页数:14
相关论文
共 50 条
  • [1] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Hantsoo, Liisa
    Ward-O'Brien, Deborah
    Czarkowski, Kathryn A.
    Gueorguieva, Ralitza
    Price, Lawrence H.
    Epperson, C. Neill
    PSYCHOPHARMACOLOGY, 2014, 231 (05) : 939 - 948
  • [2] Shuhe granule for insomnia: study protocol for a double-blind, randomized, placebo-controlled trial
    Gao, Yu
    Chen, Xiangbin
    Li, Yuxi
    Shen, Yuchuan
    Chen, Xinyi
    Xu, Qing
    Peng, Mengling
    Xu, Wen
    Yuan, Jiamin
    Hu, Yuanyuan
    Chen, Xiankun
    Xu, Biyun
    Yang, Zhimin
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [3] Eszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Pollack, Mark H.
    Hoge, Elizabeth A.
    Worthington, John J.
    Moshier, Samantha J.
    Wechsler, Rachel S.
    Brandes, Mina
    Simon, Naomi M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (07) : 892 - 897
  • [4] Escitalopram in the Treatment of Adolescent Depression: A Randomized, Double-Blind, Placebo-Controlled Extension Trial
    Findling, Robert L.
    Robb, Adelaide
    Bose, Anjana
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (07) : 468 - 480
  • [5] A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
    Liisa Hantsoo
    Deborah Ward-O’Brien
    Kathryn A. Czarkowski
    Ralitza Gueorguieva
    Lawrence H. Price
    C. Neill Epperson
    Psychopharmacology, 2014, 231 : 939 - 948
  • [6] A Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia: An Effective Treatment for Comorbid Insomnia and Depression
    Ashworth, Damon K.
    Sletten, Tracey L.
    Junge, Moira
    Simpson, Katrina
    Clarke, David
    Cunnington, David
    Rajaratnam, Shantha M. W.
    JOURNAL OF COUNSELING PSYCHOLOGY, 2015, 62 (02) : 115 - 123
  • [7] Efficacy of individualized homeopathic treatment of insomnia: Double-blind, randomized, placebo-controlled clinical trial
    Michael, James
    Singh, Subhas
    Sadhukhan, Satarupa
    Nath, Arunava
    Kundu, Nivedita
    Magotra, Nitin
    Dutta, Susmit
    Parewa, Maneet
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 43 : 53 - 59
  • [8] The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial
    Tek, Cenk
    Palmese, Laura B.
    Krystal, Andrew D.
    DeGeorge, Pamela C.
    Reutenauer, Erin L.
    Guloksuz, Sinan
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 341S - 342S
  • [9] A Randomized, Double-Blind, Placebo-Controlled Trial of Eszopiclone for the Treatment of Insomnia in Patients with Chronic Low Back Pain
    Goforth, Harold W.
    Preud'homme, Xavier A.
    Krystal, Andrew D.
    SLEEP, 2014, 37 (06) : 1053 - 1060
  • [10] Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lavretsky, Helen
    Reinlieb, Michelle
    St Cyr, Natalie
    Siddarth, Prabha
    Ercoli, Linda M.
    Senturk, Damla
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (06) : 561 - 569